Order Article Reprints

Ozbay MF, Harputluoglu H, Karaca M, Tekin O, Şendur MAN, Kaplan MA, Sahin B, Geredeli C, Teker F, Tural D, et al. Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes. Cancers. 2024; 16(22):3880. https://doi.org/10.3390/cancers16223880

Ozbay, Mehmet Fatih, Hakan Harputluoglu, Mustafa Karaca, Omer Tekin, Mehmet Ali Nahit Şendur, Muhammed Ali Kaplan, Berksoy Sahin, Caglayan Geredeli, Fatih Teker, Deniz Tural, and et al. 2024. "Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes" Cancers 16, no. 22: 3880. https://doi.org/10.3390/cancers16223880

Ozbay, M. F., Harputluoglu, H., Karaca, M., Tekin, O., Şendur, M. A. N., Kaplan, M. A., Sahin, B., Geredeli, C., Teker, F., Tural, D., Saglam, S., Çil, T., Bilici, A., Erol, C., Kalkan, Z., Bayram, E., Selvi, O., Gültürk, İ., Göksu, S. S., & Tatlı, A. M. (2024). Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes. Cancers, 16(22), 3880. https://doi.org/10.3390/cancers16223880